Author:
Nahmias Jeffry,Zakrison Tanya L.,Haut Elliott R.,Gurney Onaona,Joseph Bellal,Hendershot Kimberly,Ghneim Mira,Stey Anne,Hoofnagle Mark H.,Bailey Zinzi,Rattan Rishi,Richardson Joseph B.,Santos Ariel P.,Zarzaur Ben
Reference17 articles.
1. Increasing participation of women in early phase clinical trials approved by the FDA;Pinnow;Womens Health Issues,2009
2. Gender medicine and oncology: report and consensus of an ESMO workshop;Wagner;Ann Oncol,2019
3. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study;Walli-Attaei;Lancet,2020
4. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use;Heidari;Res Integr Peer Rev,2016
5. Sex and gender influences on pharmacological response: an overview;Franconi;Expert Rev Clin Pharmacol,2014
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献